Search filters

List of works by Wojciech Larczynski

Atorvastatin attenuates oxidative stress in patients with chronic kidney disease.

scientific article published in March 2010

Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.

scientific article

Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline

scientific article

Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.

scientific article published in January 2008

Effects of N-acetylcysteine on angiotensin-converting enzyme plasma activity in patients with chronic kidney diseases.

scientific article published on 19 May 2008

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

scientific article published on 2 December 2008

Pentoxifylline old drug or new hope for nephrology?

scientific article

Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives.

scientific article

Spironolactone attenuates oxidative stress in patients with chronic kidney disease.

scientific article published on 29 September 2008

The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.

scientific article published in July 2010

The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study

scientific article published on 18 December 2008

Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.

scientific article published on 18 April 2008